ImmunoACT

Industry

  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals

Other Names/Subsidiaries

  • ImmunoAdoptive Cell Therapy
See more in Biomedtracker

Latest on ImmunoACT

Scrip

How Miltenyi Hopes To Help Shape India’s CGT Landscape

 
• By Anju Ghangurde

German multinational Miltenyi Biotec’s senior leadership sees significant opportunities for India in the cell and gene therapy space if it can get things right in terms of shaping the regulatory frame

Scrip

Trends To Track In India: Deals, Big Pharma GCC Strategy And CAR-Ts In Motion

 
• By Anju Ghangurde

The new year promises to be one of multifaceted action in India ranging from deal appetite and growing big pharma interest in global capability centers (GCCs), besides some big-ticket launches, to re

In Vivo

Innovation And Accessibility: India’s Advanced Therapy Pricing Challenge

 
• By Smruthi Suryaprakash, Souparno Bhattacharya, Shree Arun Kumar, Priyanka Aggarwal, Narendra Chirmule, and Michael Choy

Advanced therapies, including cell and gene therapy, have demonstrated the potential to revolutionize the treatment of previously incurable diseases. Since the first CAR-T was introduced in 2017, the